Lenacapavir and its Impurities

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. Reference standards of Lenacapavir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 41 results for Lenacapavir Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 12 2090000

Lenacapavir

Lenacapavir

  • Catalogue No.:PA 12 2090000

  • CAS :

    2189684-44-2

  • Molecular Formula : C39H32ClF10N7O5S2

  • Molecular Weight : 968.28

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091000

2-((3bR,4aS)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

2-((3bR,4aS)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

  • Catalogue No.:PA 12 2091000

  • CAS :

    2189680-65-5

  • Molecular Formula : C10H7F5N2O2

  • Molecular Weight : 282.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091001

N-((S)-1-(3-(4-Chloro-3-(N-(methylsulfonyl)methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(N-(methylsulfonyl)methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091001

  • CAS :

    2189684-58-8

  • Molecular Formula : C40H34ClF10N7O7S3

  • Molecular Weight : 1046.37

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091002

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

  • Catalogue No.:PA 12 2091002

  • CAS :

    3025145-62-1

  • Molecular Formula : C15H19BF3N3O2

  • Molecular Weight : 341.14

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091003

Ethyl 2-((3bS,4aR)-3-(trifluoromethyl)-4,4a-dihydrospiro[cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-5,2'-[1,3]dithiolane]-1(3bH)-yl)acetate

Ethyl 2-((3bS,4aR)-3-(trifluoromethyl)-4,4a-dihydrospiro[cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-5,2'-[1,3]dithiolane]-1(3bH)-yl)acetate

  • Catalogue No.:PA 12 2091003

  • CAS :

    2375020-09-8

  • Molecular Formula : C14H15F3N2O2S2

  • Molecular Weight : 364.4

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091004

Ethyl 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetate

Ethyl 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetate

  • Catalogue No.:PA 12 2091004

  • CAS :

    2375020-13-4

  • Molecular Formula : C12H11F5N2O2

  • Molecular Weight : 310.22

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091005

2-((3bS,4aR)-5-Oxo-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

2-((3bS,4aR)-5-Oxo-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

  • Catalogue No.:PA 12 2091005

  • CAS :

    NA

  • Molecular Formula : C10H7F3N2O3

  • Molecular Weight : 260.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091006

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-2H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-2-yl)acetic Acid

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-2H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-2-yl)acetic Acid

  • Catalogue No.:PA 12 2091006

  • CAS :

    NA

  • Molecular Formula : C10H7F5N2O2

  • Molecular Weight : 282.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091007

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic Acid

  • Catalogue No.:PA 12 2091007

  • CAS :

    1620056-83-8

  • Molecular Formula : C10H7F5N2O2

  • Molecular Weight : 282.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091008

(S)-1-(6-Bromo-3-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

(S)-1-(6-Bromo-3-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

  • Catalogue No.:PA 12 2091008

  • CAS :

    NA

  • Molecular Formula : C13H10BrClF2N2

  • Molecular Weight : 347.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091009

(S)-1-(3-Bromo-6-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

(S)-1-(3-Bromo-6-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

  • Catalogue No.:PA 12 2091009

  • CAS :

    NA

  • Molecular Formula : C13H10BrClF2N2

  • Molecular Weight : 347.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091010

(S)-1-(3-Bromo-6-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine compound with (S)-1-(6-bromo-3-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine (1:1)

(S)-1-(3-Bromo-6-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine compound with (S)-1-(6-bromo-3-chloropyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine (1:1)

  • Catalogue No.:PA 12 2091010

  • CAS :

    NA

  • Molecular Formula : C13H10BrClF2N2

  • Molecular Weight : 347.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091011

7-Bromo-4-iodo-1H-indazol-3-amine

7-Bromo-4-iodo-1H-indazol-3-amine

  • Catalogue No.:PA 12 2091011

  • CAS :

    935660-94-9

  • Molecular Formula : C7H5BrIN3

  • Molecular Weight : 337.95

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091012

Deschloro Lenacapavir

Deschloro Lenacapavir

  • Catalogue No.:PA 12 2091012

  • CAS :

    3025145-47-2

  • Molecular Formula : C39H33F10N7O5S2

  • Molecular Weight : 933.84

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091013

N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methylbut-3-en-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methylbut-3-en-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091013

  • CAS :

    NA

  • Molecular Formula : C38H28ClF10N7O3S

  • Molecular Weight : 888.18

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091014

Hydroxy Desmethylsulfonyl Lenacapavir

Hydroxy Desmethylsulfonyl Lenacapavir

  • Catalogue No.:PA 12 2091014

  • CAS :

    3025145-44-9

  • Molecular Formula : C38H30ClF10N7O4S

  • Molecular Weight : 906.2

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091015

(S)-N-(7-(2-(1-Amino-2-(3,5-Difluorophenyl)ethyl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-3-yl)-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-yl)methanesulfonamide

(S)-N-(7-(2-(1-Amino-2-(3,5-Difluorophenyl)ethyl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-3-yl)-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-yl)methanesulfonamide

  • Catalogue No.:PA 12 2091015

  • CAS :

    3053923-46-6

  • Molecular Formula : C29H27ClF5N5O4S2

  • Molecular Weight : 704.13

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091019

N-((S)-1-(3-(3-Amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(3-Amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091019

  • CAS :

    2375020-20-3

  • Molecular Formula : C38H30ClF10N7O3S

  • Molecular Weight : 890.2

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091018

N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5-oxo-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5-oxo-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091018

  • CAS :

    NA

  • Molecular Formula : C39H32ClF8N7O6S2

  • Molecular Weight : 946.29

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091017

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)-N-((S)-2-(3,5-difluorophenyl)-1-(6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)ethyl)acetamide

2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)-N-((S)-2-(3,5-difluorophenyl)-1-(6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)ethyl)acetamide

  • Catalogue No.:PA 12 2091017

  • CAS :

    NA

  • Molecular Formula : C29H25F7N4O3S

  • Molecular Weight : 642.59

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091016

(S)-N-(1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)acetamide

(S)-N-(1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)acetamide

  • Catalogue No.:PA 12 2091016

  • CAS :

    NA

  • Molecular Formula : C31H29ClF5N5O5S2

  • Molecular Weight : 746.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091020

(R)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-L-leucinate

(R)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-L-leucinate

  • Catalogue No.:PA 12 2091020

  • CAS :

    NA

  • Molecular Formula : C21H25Br2F2N3O3

  • Molecular Weight : 565.25

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091021

(R)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-D-leucinate

(R)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-D-leucinate

  • Catalogue No.:PA 12 2091021

  • CAS :

    NA

  • Molecular Formula : C21H25Br2F2N3O3

  • Molecular Weight : 565.25

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091022

(R)-1-(3-Bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

(R)-1-(3-Bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

  • Catalogue No.:PA 12 2091022

  • CAS :

    NA

  • Molecular Formula : C19H19BrF2N2O2S

  • Molecular Weight : 457.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091023

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-L-leucinate

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine acetyl-L-leucinate

  • Catalogue No.:PA 12 2091023

  • CAS :

    2375020-37-2

  • Molecular Formula : C21H25Br2F2N3O3

  • Molecular Weight : 565.25

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091024

1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-one

1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-one

  • Catalogue No.:PA 12 2091024

  • CAS :

    2375021-58-0

  • Molecular Formula : C13H7Br2F2NO

  • Molecular Weight : 391.01

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091025

7-Bromo-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

7-Bromo-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

  • Catalogue No.:PA 12 2091025

  • CAS :

    2189684-52-2

  • Molecular Formula : C9H6BrClF3N3

  • Molecular Weight : 328.52

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091026

1-(3-Bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-one

1-(3-Bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-one

  • Catalogue No.:PA 12 2091026

  • CAS :

    3044746-78-0

  • Molecular Formula : C19H16BrF2NO3S

  • Molecular Weight : 456.3

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091027

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

  • Catalogue No.:PA 12 2091027

  • CAS :

    1626481-45-5

  • Molecular Formula : C13H10Br2F2N2

  • Molecular Weight : 392.04

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091028

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethanamine Hydrochloride

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethanamine Hydrochloride

  • Catalogue No.:PA 12 2091028

  • CAS :

    1626335-72-5

  • Molecular Formula : C13H11Br2ClF2N2

  • Molecular Weight : 428.5

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091029

N-(1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-1,1-diphenylmethanimine

N-(1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-1,1-diphenylmethanimine

  • Catalogue No.:PA 12 2091029

  • CAS :

    2375019-72-8

  • Molecular Formula : C26H18Br2F2N2

  • Molecular Weight : 556.25

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091030

1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine

  • Catalogue No.:PA 12 2091030

  • CAS :

    2375019-73-9

  • Molecular Formula : C13H10Br2F2N2

  • Molecular Weight : 392.04

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091031

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine (R)-2-hydroxy-2-phenylacetate

(S)-1-(3,6-Dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine (R)-2-hydroxy-2-phenylacetate

  • Catalogue No.:PA 12 2091031

  • CAS :

    2375019-74-0

  • Molecular Formula : C21H18Br2F2N2O3

  • Molecular Weight : 544.19

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091032

(3bS,4aR)-3-(Trifluoromethyl)-1,3b,4,4a-tetrahydrospiro[cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-5,2'-[1,3]dithiolane]

(3bS,4aR)-3-(Trifluoromethyl)-1,3b,4,4a-tetrahydrospiro[cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-5,2'-[1,3]dithiolane]

  • Catalogue No.:PA 12 2091032

  • CAS :

    2375020-08-7

  • Molecular Formula : C10H9F3N2S2

  • Molecular Weight : 278.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091033

Diisopropylammonium (Z)-2,2,2-trifluoro-1-((1R,5S)-3-oxospiro[bicyclo[3.1.0]hexane-2,2'-[1,3]dithiolan]-4-ylidene)ethan-1-olate

Diisopropylammonium (Z)-2,2,2-trifluoro-1-((1R,5S)-3-oxospiro[bicyclo[3.1.0]hexane-2,2'-[1,3]dithiolan]-4-ylidene)ethan-1-olate

  • Catalogue No.:PA 12 2091033

  • CAS :

    NA

  • Molecular Formula : C16H24F3NO2S2

  • Molecular Weight : 383.49

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091034

4-Chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

4-Chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

  • Catalogue No.:PA 12 2091034

  • CAS :

    NA

  • Molecular Formula : C9H7ClF3N3

  • Molecular Weight : 249.62

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091035

(3-Amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)boronic acid

(3-Amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)boronic acid

  • Catalogue No.:PA 12 2091035

  • CAS :

    2375021-56-8

  • Molecular Formula : C9H8BClF3N3O2

  • Molecular Weight : 293.44

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 090125

Lenacapavir-D5

Lenacapavir-D5

  • Catalogue No.:PA STI 090125

  • CAS :

    NA

  • Molecular Formula : C39H27D5ClF10N7O5S2

  • Molecular Weight : 973.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091036

N-((S)-1-(3-(4-Chloro-3-(N-methylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(N-methylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091036

  • CAS :

    2939763-16-1

  • Molecular Formula : C40H34ClF10N7O5S2

  • Molecular Weight : 982.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091037

N-((S)-1-(3-(4-Chloro-3-(N-ethylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-(N-ethylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091037

  • CAS :

    3025145-48-3

  • Molecular Formula : C41H36ClF10N7O5S2

  • Molecular Weight : 996.34

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 12 2091038

N-((S)-1-(3-(4-Chloro-3-((chloromethyl)sulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

N-((S)-1-(3-(4-Chloro-3-((chloromethyl)sulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

  • Catalogue No.:PA 12 2091038

  • CAS :

    NA

  • Molecular Formula : C39H31Cl2F10N7O5S2

  • Molecular Weight : 1002.73

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates